Candida spp. with acquired echinocandin resistance, France, 2004-2010

Emerging Infectious Diseases

Volumn 18, Issue 1, 2012, Pages 86-90

  Dannaoui, Eric ^a   Desnos Ollivier, Marie ^a   Garcia Hermoso, Dea ^a   Grenouillet, Fredéric ^b   Cassaing, Sophie ^c   Baixench, Marie Thérèse ^d   Bretagne, Stéphane ^a   Dromer, Françoise ^a   Lortholary, Olivier ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; MICAFUNGIN;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRANCE; FUNGAL STRAIN; FUNGUS ISOLATION; GENE MUTATION; GENOTYPE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; NUCLEOTIDE SEQUENCE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FEMALE; FRANCE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; YOUNG ADULT;

EID: 84856576829     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1801.110556     Document Type: Article

References (15)

1. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503-35. doi:10.1086/596757
2. Baixench MT, Aoun N, Desnos-Ollivier M, Garcia-Hermoso D, Bretagne S, Ramires S, et al. Acquired resistance to echinocandins in Candida albicans: case report and review. J Antimicrob Chemother. 2007;59:1076-83. doi:10.1093/jac/dkm095
3. Pfeiffer CD, Garcia-Effron G, Zaas AK, Perfect JR, Perlin DS, Alexander BD. Breakthrough invasive candidiasis in patients on micafungin. J Clin Microbiol. 2010;48:2373-80. doi:10.1128/JCM.02390-09
4. Sun HY, Singh N. Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review. Int J Antimicrob Agents. 2010;35:211-8. doi:10.1016/j.ijantimicag.2009. 09.020
5. Perlin DS. Resistance to echinocandin-class antifungal drugs. Drug Resist Updat. 2007;10:121-30. doi:10.1016/j.drup.2007.04.002
6. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing. (EUCAST). EUCAST definitive document EDef 7.1: method for the determination of broth microdilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect. 2008;14:398-405. doi:10.1111/j.1469-0691.2007.01935.x
7. Desnos-Ollivier M, Bretagne S, Raoux D, Hoinard D, Dromer F, Dannaoui E. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing. Antimicrob Agents Chemother. 2008;52:3092-8. doi:10.1128/AAC.00088-08
8. Katiyar S, Pfaller M, Edlind T. Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility. Antimicrob Agents Chemother. 2006;50:2892-4. doi:10.1128/AAC.00349-06
9. Foulet F, Nicolas N, Eloy O, Botterel F, Gantier JC, Costa JM, et al. Microsatellite marker analysis as a typing system for Candida glabrata. J Clin Microbiol. 2005;43:4574-9. doi:10.1128/ JCM.43.9.4574-4579.2005
10. Garcia-Hermoso D, Cabaret O, Lecellier G, Desnos-Ollivier M, Hoinard D, Raoux D, et al. Comparison of microsatellite length polymorphism and multilocus sequence typing for DNA-based typing of Candida albicans. J Clin Microbiol. 2007;45:3958-63. doi:10.1128/JCM.01261-07
11. Garcia-Hermoso D, MacCallum DM, Lott TJ, Sampaio P, Serna MJ, Grenouillet F, et al. Multicenter collaborative study for standardization of Candida albicans genotyping using a polymorphic microsatellite marker. J Clin Microbiol. 2010;48:2578-81. doi:10.1128/JCM.00040-10
12. Arendrup MC, Park S, Rodriguez-Tudela JL, Hope W, Lass-Flörl C, Donnelly PJ, et al. EUCAST susceptibility testing of Candida species to echinocandins: improved separation between wild type isolates and fks mutants by supplementation of BSA to the test medium. 21st European Congress of Clinical Microbiology and Infectious Diseases 27th International Congress of Chemotherapy; 2011; Milan, Italy.
13. Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, et al. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat. 2011;14:164-76. doi:10.1016/j.drup.2011.01.004
14. Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother. 2011;55:532-8. doi:10.1128/AAC.01128-10
15. Blanchard E, Lortholary O, Boukris-Sitbon K, Desnos-Ollivier M, Dromer F, Guillemot D, et al. Prior caspofungin exposure in patients with haematological malignancies is a risk factor for subsequent fungemia due to decreased susceptible Candidda spp.: a case-control study in Paris, France. Antimicrob Agents Chemother. 2011;55:5358-61. doi:10.1128/AAC.00690-11